SOX-associated Lambert-Eaton myasthenic syndrome (Q96647): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 12:40, 16 August 2026
Lambert-Eaton myasthenic syndrome with SOX1 antibodies is an autoimmune disorder of the neuromuscular junction. SOX1-positive antibodies are thought to be a specific marker for Lambert-Eaton myasthenic syndrome associated with small cell lung cancer, although they are also found in patients with small cell lung cancer but without paraneoplastic neurological disorders. No relation to any clinical characteristic or survival effect has been found for SOX1-positive patients.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_973831097 |
||
| English | SOX-associated Lambert-Eaton myasthenic syndrome |
Lambert-Eaton myasthenic syndrome with SOX1 antibodies is an autoimmune disorder of the neuromuscular junction. SOX1-positive antibodies are thought to be a specific marker for Lambert-Eaton myasthenic syndrome associated with small cell lung cancer, although they are also found in patients with small cell lung cancer but without paraneoplastic neurological disorders. No relation to any clinical characteristic or survival effect has been found for SOX1-positive patients. |
Statements
CID11:ID_973831097
0 references
dki-india-ID_973831097
0 references
Concluído
0 references
15 August 2026
0 references
